Full Text
EE286 Cost-Effectiveness of NALIRIFOX As a First-Line Treatment for Metastatic Pancreatic Cancer in Taiwan

Abstract

Authors

MING-YU HONG Chen-Han Chueh Wei-ming Huang Nai-Jung Chiang Yi-Wen Tsai

Back to Volume 28, Supplemental Issue 6S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×